Search Results 1881-1890 of 17035 for monoclonal antibody
... antibody (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. Control Subjects for the Generation of Induced ...
Known to have tested positive for hepatitis B virus surface antigen, hepatitis C virus antibody, or HIV; Any underlying condition that predisposes subject to ...
... antibodies. The second is a cellular marker, and more generic in nature--circulating VEGF receptor-2 positive cells found in peripheral blood, some of which ...
... antibodies, omalizumab) or systemic corticosteroids with a daily dose >10 mg of prednisone or equivalent, during 5 half-lives prior to screening or during ...
... antibody) within 28 days of starting study treatment. Prior radiation therapy within 28 days of starting the study treatment, except radiation therapy for ...
Documented chronic HCV GT1, GT4, or GT6 with no evidence of non-typable or mixed genotype infection (positive for anti-HCV antibody, HCV RNA, or any of the ...
Clinically significant hepatitis at Screening, or hepatitis C antibody positive, hepatitis B surface antigen positive, or human immunodeficiency virus (HIV) ...
... antibody based therapy, etc.) Known intolerance or hypersensitivity to everolimus or other rapamycin analogs (e.g. sirolimus, temsirolimus); Known impairment ...
Positive test for HIV or hepatitis C antibodies. Positive test for HBsAg or HBcAb (a subject whose HBsAg is negative and HBcAb is positive may be enrolled ...
Patients known to have tested positive on HIV antibody test. Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.